Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT05785494

Web-based Support for Family Caregivers of Patients With Advanced Cancer

For family caregivers of patients with advanced cancer, preparedness for caregiving is crucial for maintaining health and quality of life both during care and after the death of the patient. This project contributes to earlier research funded by the Swedish Cancer Society, about an intervention that was delivered by a multi-professional team and proved to be successful in promoting preparedness. However, such interventions are often costly and logistically challenging. In addition, the Covid-19 pandemic has further significantly raised the need for digital alternatives in healthcare. As a possible solution, an evidence-based intervention, narstaende.se, has been developed consisting of recorded videos of conversations between clinicians and family caregivers (actors), linked to informational texts and a moderated chat forum. The intervention was pilot tested during 2020 and 2021, exploring feasibility, content and family caregivers' experiences. As preliminary results are promising, the intervention is taken one step further and tested as a web-based intervention in a larger scale.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Marie Cederschiöld University

Stockholm, 100 61, Sweden

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Being a family caregiver, over 18 years of age, to a person with life-threatening illness cared for in specialized home care.

Exclusion criteria

  • Not being able to communicate in Swedish

Treatment and study plan

Narstaende.se

Other

Web-site with supportive information, videos and chat forum targeting family caregivers of patients with life-threatening illness.

Primary outcomes

  1. Change in Preparedness for caregiving

    Time frame: At baseline (before intervention), change from baseline after 4-6 weeks (follow-up 1) and after 8-10 weeks (follow-up 2)

    Preparedness for caregiving scale (PCS)

Secondary outcomes

  1. Change in Quality of Life

    Time frame: At baseline (before intervention), change from baseline after 4-6 weeks (follow-up 1) and after 8-10 weeks (follow-up 2)

    The Quality of Life in Life-Threatening Illness Family caregiver version (QOLLTI-F)

  2. Change in health

    Time frame: At baseline (before intervention), change from baseline after 4-6 weeks (follow-up 1) and after 8-10 weeks (follow-up 2)

    RAND- 36

  3. Change in Anxiety and Depression

    Time frame: At baseline (before intervention), change from baseline after 4-6 weeks (follow-up 1) and after 8-10 weeks (follow-up 2)

    The Hospital Anxiety and Depression Scale (HADS)

  4. Change in pre-loss grief

    Time frame: At baseline (before intervention), change from baseline after 4-6 weeks (follow-up 1) and after 8-10 weeks (follow-up 2)

    Prolonged Grief-12

  5. Change in post-loss grief

    Time frame: At baseline (before intervention), change from baseline after 4-6 weeks (follow-up 1) and after 8-10 weeks (follow-up 2)

    Prolonged Grief-13

Sponsors and collaborators

Lead sponsor

Ersta Sköndal University College

Other

Registry information

Official study title

Web-based Support to Promote Preparedness for Caregiving Among Family Caregivers of Patients With Advanced Cancer

Important dates

Study start
2022
Primary completion
2023
Study completion
2026
First posted
Mar 27, 2023
Registry last updated
Aug 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.